Our new podcast: Meet...
We know. Podcasts are so last year - but this one you won't want to miss. Whether it’s a rumor that won’t die, a new product announcement, or just a really good Macintosh or iPhone app find that we have to let you know about, we’ll make sure it’s covered on Appletellcast.
iPhone App Reviews
iPhone Apps. They were great when the App Store was first announced and we could all pick and chose what we wanted, but the number is now overwhelming. Here at Appletell, we'll detail the great iPhone apps we find, and steer you clear from those that aren't worth it even if they're free.
iPhone Game Reviews
As Apple turns the iPhone into one of the most popular gaming devices, the staff of Appletell--gamers and Apple fans alike--are here to help you get the most entertainment value out of your app store purchases.





The wine project seeks to deliver an open source implementation of the Microsoft Win32 API, to allow for source-code level compatibility between Microsoft Windows applications and other OS platforms, including Unix, various flavors of Linux, and Mac OS X. This is the key difference between wine and emulators such as Parallels and VMWare, which deliver a virtual machine in which Windows can run. Wine does not require a valid Windows license, as do emulators; rather it provides an open source version of the Windows API. Darwine is the Mac OS X-specific compile of the wine source code.
As an open source application, Darwine offers several benefits that emulators do not. First, the price tag: it’s free. Parallels or VMWare both require a license, plus the cost of a Windows license. Another benefit is the extensibility of Darwinesince the source code is open and available, it is possible to customize the functionality to meet specific user requirements. And finally, Darwine offers the access to the power and functionality of OS X, while retaining native compatibility with any mission-critical Windows applications.
Via [Low End Mac]
Subscribe to keep up with the latest Apple news and rumors! -
Subscribe to our feed